Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Cancer|August 10, 2013
Glioma-derived galectin-1 regulates innate and adaptive antitumor immunityTina Verschuere, Jaan Toelen, Wim Maes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 6, 2019
Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumorsAn Coosemans, Thaïs Baert, Jolien Ceusters, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2012
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trialHilko Ardon, Stefaan W Van Gool, Tina Verschuere, et al.
The Journal of Investigative Dermatology|May 25, 2012
Galectin-1 in melanoma biology and related neo-angiogenesis processesVéronique Mathieu, Elisabeth Martin de Lassalle, Jaan Toelen, et al.
EMBO Molecular Medicine|October 18, 2017
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growthThomas Mathivet, Claire Bouleti, Matthias Van Woensel, et al.
The Lancet. Oncology|August 18, 2018
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trialMartin J van den Bent, Martin Klein, Marion Smits, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC TrialKaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, et al.
Pageof 2